Samar Ibrahim
@SamarHIbrahimMD
Followers
364
Following
242
Media
3
Statuses
50
Pediatric transplant hepatologist, physician scientist, mechanisms of liver injury and inflammation in NASH@MayoClinic, opinions are mine.
Minnesota, USA
Joined August 2019
RT @EKostallari_PhD: @MayoClinicGIHep reception @TLM23! So good to see collaborators, friends and mentors, all concentrated in one room! ☺️….
0
5
0
RT @EKostallari_PhD: ‼️Happening right now @TLM23! MASLD and MASH session! @Qianqian_C_Guo from @SamarHIbrahimMD lab at @MayoClinicGIHep is….
0
1
0
RT @AASLDPresident: It has been a great honor serving as your AASLD President. Thank you. And @norahterrault, I can't wait to see the path….
0
17
0
RT @AASLDtweets: The highest honor. Congratulations to our Distinguished Award Recipients! ✨.Gianfranco Alpini, PhD, FAASLD @AlpiniDanilo….
0
10
0
RT @EKostallari_PhD: Hepatic fibrosis - basic session moderated by Drs. Brenner and @SammiShuang! It is going to be an outstanding session!….
0
1
0
RT @Rabihghazi_95: Proud of you @rashajaoudeh ⭐! .Great study comparing isolated kidney vs simultaneous liver-kidney transplant in patients….
0
7
0
Please join us to discuss the impact of social determinants of health on liver transplant outcomes! @jesshochbergmd.
1
0
2
SPLIT Webinar - November 2, 2022 - Social Determinants of Health in Pediatric Liver Transplantation: Challenges and Opportunities
2
2
5
RT @Qianqian_C_Guo: Fresh and toasty:), our new paper is out! Uncovering the amazing cross talk from our favorite LSECs to the stellate cel….
0
5
0
If you missed the live webinar, it will be available on Demand soon, stay tuned!.
0
2
7
RT @HEP_Journal: REVIEW: #Cholestatic liver diseases of #genetic etiology: Advances and controversies.@SamarHIbrahimMD @BinitaKamath .#Live….
0
3
0
RT @MCTransplntSurg: @SamarHIbrahimMD is a gastroenterologist and #transplant hepatologist specializing in #liver disease in children from….
0
1
0
Join us at DDW 2022, May 21-24 in San Diego, CA. Update Your Knowledge, Expand Your Network and Access Inspiring Research. I am moderating session Novel Pathways to Pathogenesis and Therapeutic Targets in Cholestatic and Autoimmune Liver Disease.
0
1
6
RT @PetraHirsova: Join us this Thursday to learn more about mass cytometry #CyTOF . @audayan @SamarHIbrahimMD @Xavier_Revelo @AASLDtweets.
0
6
0
Amazing!.
A cell in motion deposits migrasomes at the trailing edge. Green is CD63-GFP #microscopymonday #nikonAXR
0
0
3
Metabolic dysfunction was associated with fibrosis and higher liver stiffness!.
Metabolic dysfunction–associated fatty liver disease improves detection of high liver #stiffness: The #Rotterdam Study.#LiverTwitter #MAFLD #NAFLD.
0
0
6
RT @HEP_Journal: Metabolic dysfunction–associated fatty liver disease improves detection of high liver #stiffness: The #Rotterdam Study.#Li….
0
12
0
RT @bruixj: The task as AE in @HEP_Journal is intense, but easy if surrounded by a team of experts and friends in the Board!! Clinical and….
0
7
0
RT @SSookoian: Thank you @AASLDtweets and @EASLnews for giving us the chance for having a consensus (“a general accord of different parts i….
0
7
0